Naveris, Inc.

WALTHAM, MA · Founded 2017 · CIK 0001789232 · Medtech · Acquired

Highly sensitive blood tests for early detection of viral cancers

naveris.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$34M
3 Form D · Jul 2024
27 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$650,000
Private capital raisedForm D · SEC$15,442,997
Private capital raisedForm D · SEC$17,491,836
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1260BioAmp Diagnostics, Inc.——
1261Innerspec Technologies Inc——
1262DeVoro Medical Inc.—$26M
1263Naveris, Inc.—$34M
1264TJB Medical, Inc.—$11K
1265QCMedchain LLC——
1266CytoTronics, Inc.—$14M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Barry BergerDirector
  • Francis CrispinoDirector
  • Piyush GuptaDirector · Executive Officer
  • Philip HaydonDirector
  • Sophie KornowskiDirector
  • James McNallyDirector · Executive Officer
  • Philip StephensExecutive Officer
  • Anne StoneDirector

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.